Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

15.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
4.5K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

18.5K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.5K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

8.5K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.5K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

526
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
526
What are Second Messengers?01:12

What are Second Messengers?

90.6K
Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
90.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BetaDescribe: Providing rich descriptions from protein sequences.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Cancer frenemy pathways: Inducing immunogenic cell death by exploiting apoptosis-interferon antagonism with oncolytic viruses.

Molecular therapy. Oncology·2026
Same author

Quinone reductase 2 <i>reads</i> H3 serotonylation to support neuronal maturation.

bioRxiv : the preprint server for biology·2026
Same author

Induction of caspase-mediated suppression of interferon signaling potentiates viral oncolysis of resistant tumor cells.

Cell communication and signaling : CCS·2026
Same author

Suppression of neuronal eEF2K alleviates cognitive deficits and apathy-like behavior in APP/PS1 AD model mice.

Research square·2026
Same author

Overactive Neuronal eEF2K/eEF2 signaling is associated with cognitive impairment and apathy-like behavior.

Molecular psychiatry·2025

Related Experiment Video

Updated: Jan 30, 2026

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
10:05

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle

Published on: March 5, 2019

6.9K

PKR: A Kinase to Remember.

Shunit Gal-Ben-Ari1, Iliana Barrera1, Marcelo Ehrlich2

  • 1Laboratory of Molecular and Cellular Mechanisms Underlying Learning and Memory, Sagol Department of Neurobiology, University of Haifa, Haifa, Israel.

Frontiers in Molecular Neuroscience
|January 29, 2019
PubMed
Summary
This summary is machine-generated.

Protein kinase R (PKR) is a key regulator linking metabolic stress and aging. Targeting PKR may offer new therapeutic strategies for age-related diseases like cancer and neurodegeneration.

Keywords:
Alzheimer’s diseasePKRagingcancerlearning and memorymetabolic stressprotein synthesissignal transduction

More Related Videos

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
12:43

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE

Published on: July 29, 2014

12.7K
Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

19.4K

Related Experiment Videos

Last Updated: Jan 30, 2026

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
10:05

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle

Published on: March 5, 2019

6.9K
Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
12:43

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE

Published on: July 29, 2014

12.7K
Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

19.4K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Gerontology

Background:

  • Aging is a significant risk factor for numerous diseases, including metabolic syndrome, cancer, inflammation, and neurodegeneration.
  • Understanding the common mechanisms underlying aging is crucial for developing strategies against age-related diseases.
  • Aging can be biochemically defined as prolonged metabolic stress and the cellular responses to it.

Purpose of the Study:

  • To investigate the role of protein kinase R (PKR) in mediating the effects of aging and metabolic stress.
  • To explore PKR's function in regulating cellular processes relevant to cancer, inflammation, and brain function.
  • To identify PKR as a potential therapeutic target for age-related conditions.

Main Methods:

  • Literature review and data integration from open data sources.
  • Analysis of PKR's role in metabolic information transfer and cellular regulation.
  • Examination of signaling cascades upstream and downstream of PKR.

Main Results:

  • PKR acts as a central regulator, transferring metabolic information and influencing cellular functions.
  • Imbalanced PKR activation is linked to metabolic parameters, forming a feedforward loop.
  • PKR's involvement is highlighted in cancer, inflammation, and brain function.

Conclusions:

  • PKR plays a critical role in cellular responses to metabolic stress and aging.
  • Manipulating PKR expression or activation presents a potential therapeutic avenue.
  • Targeting PKR could help shift detrimental age/metabolic-dependent states towards healthier outcomes.